Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 6, 2008, Pages 742-753

  Chen, Chien Lung ^a   Huang, Shoei K Stephen ^b   Lin, Jiunn Lee ^c   Lai, Ling Ping ^c   Lai, Shao Chuan ^a   Liu, Chia Wei ^a   Chen, Wen Chi ^a   Wen, Cheng Hao ^a   Lin, Chih Sheng ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Extracellular matrix; Gelatinases; Matrix metalloproteinases; MMP 9; Tissue inhibitors of metalloproteinases

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ATRIAL FIBRILLATION; EXTRACELLULAR MATRIX; HEART ATRIA; HUMANS; MATRIX METALLOPROTEINASE 9; RNA, MESSENGER; SWINE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

SUIDAE;

EID: 55649103682     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.07.007     Document Type: Article

References (51)

1. Allessie M., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 54 (2002) 230-246
2. Nattel S., Shiroshita-Takeshita A., Brundel B.J., and Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog. Cardiovasc. Dis. 48 (2005) 9-28
3. Lin C.S., and Pan C.H. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell. Mol. Life Sci. 65 (2008) 1489-1508
4. Mukherjee R., Herron A.R., Lowry A.S., Stroud R.E., Stroud M.R., Wharton J.M., et al. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am. J. Cardiol. 97 (2006) 532-537
5. Thijssen V.L., Ausma J., and Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc. Res. 52 (2001) 14-24
6. Singh R.B., Dandekar S.P., Elimban V., Gupta S.K., and Dhalla N.S. Role of proteases in the pathophysiology of cardiac disease. Mol. Cell. Biochem. 263 (2004) 241-256
7. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16 (2004) 558-564
8. Parikka V., Vaananen A., Risteli J., Salo T., Sorsa T., Vaananen H.K., et al. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol. 24 (2005) 438-447
9. Zhang X., and Nothnick W.B. The role and regulation of the uterine matrix metalloproteinase system in menstruating and non-menstruating species. Front. Biosci. 10 (2005) 353-366
10. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69 (2006) 562-573
11. Page-McCaw A., Ewald A.J., and Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8 (2007) 221-233
12. Creemers E.E., Cleutjens J.P., Smits J.F., and Daemen M.J. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ. Res. 89 (2001) 201-210
13. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90 (2002) 520-530
14. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85 (2005) 1-31
15. Coker M.L., Doscher M.A., Thomas C.V., Galis Z.S., and Spinale F.G. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations. Am. J. Physiol. 277 (1999) H777-787
16. Mukherjee R., Mingoia J.T., Bruce J.A., Austin J.S., Stroud R.E., Escobar G.P., et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H2216-2228
17. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74 (1997) 111-122
18. Chen C.L., Lin J.L., Lai L.P., Pan C.H., Huang S.K., and Lin C.S. Altered expression of FHL1, CARP, TSC-22 and P311 provide insights into complex transcriptional regulation in pacing-induced atrial fibrillation. Biochim. Biophys. Acta 1772 (2007) 317-329
19. Lin C.S., Lai L.P., Lin J.L., Sun Y.L., Hsu C.W., Chen C.L., et al. Increased expression of extracellular matrix proteins in rapid atrial pacing-induced atrial fibrillation. Heart Rhythm 4 (2007) 938-949
20. Pan C.H., Lin J.L., Lai L.P., Chen C.L., Stephen Huang S.K., and Lin C.S. Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation. FEBS Lett. 581 (2007) 526-534
21. Lin J.L., Lai L.P., Lin C.S., Du C.C., Wu T.J., Chen S.P., et al. Electrophysiological mapping and histological examinations of the swine atrium with sustained (> or = 24 h) atrial fibrillation: a suitable animal model for studying human atrial fibrillation. Cardiology 99 (2003) 78-84
22. Yan S.J., and Blomme E.A. In situ zymography: a molecular pathology technique to localize endogenous protease activity in tissue sections. Vet. Pathol. 40 (2003) 227-236
23. Turini P., Kurooka S., Steer M., Corbascio A.N., and Singer T.P. The action of phenylmethylsulfonyl fluoride on human acetylcholinesterase, chymotyrpsin and trypsin. J. Pharmacol. Exp. Ther. 167 (1969) 98-104
24. Stawowy P., Margeta C., Kallisch H., Seidah N.G., Chretien M., Fleck E., et al. Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. Cardiovasc. Res. 63 (2004) 87-97
25. Stetler-Stevenson W.G., Krutzsch H.C., Wacher M.P., Margulies I.M., and Liotta L.A. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264 (1989) 1353-1356
26. Oliver G.W., Leferson J.D., Stetler-Stevenson W.G., and Kleiner D.E. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244 (1997) 161-166
27. Goldberg G.I., Strongin A., Collier I.E., Genrich L.T., and Marmer B.L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267 (1992) 4583-4586
28. Kjeldsen L., Johnsen A.H., Sengelov H., and Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268 (1993) 10425-10432
29. Olson M.W., Bernardo M.M., Pietila M., Gervasi D.C., Toth M., Kotra L.P., et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J. Biol. Chem. 275 (2000) 2661-2668
30. Hoit B.D., Takeishi Y., Cox M.J., Gabel M., Kirkpatrick D., Walsh R.A., et al. Remodeling of the left atrium in pacing-induced atrial cardiomyopathy. Mol. Cell. Biochem. 238 (2002) 145-150
31. Nakano Y., Niida S., Dote K., Takenaka S., Hirao H., Miura F., et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J. Am. Coll. Cardiol. 43 (2004) 818-825
32. Xu J., Cui G., Esmailian F., Plunkett M., Marelli D., Ardehali A., et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109 (2004) 363-368
33. Peterson J.T., Li H., Dillon L., and Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46 (2000) 307-315
34. Boixel C., Fontaine V., Rucker-Martin C., Milliez P., Louedec L., Michel J.B., et al. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J. Am. Coll. Cardiol. 42 (2003) 336-344
35. Meiners S., Hocher B., Weller A., Laule M., Stangl V., Guenther C., et al. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension 44 (2004) 471-477
36. 2+. FEBS Lett. 238 (1988) 343-346
37. 2+. Life Sci. 51 (1992) 1049-1056
38. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell. Biol. 151 (2000) 879-889
39. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14 (2000) 163-176
40. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
41. Murphy G., Stanton H., Cowell S., Butler G., Knauper V., Atkinson S., et al. Mechanisms for pro matrix metalloproteinase activation. APMIS 107 (1999) 38-44
42. Bannikov G.A., Karelina T.V., Collier I.E., Marmer B.L., and Goldberg G.I. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J. Biol. Chem. 277 (2002) 16022-16027
43. Ogata Y., Itoh Y., and Nagase H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270 (1995) 18506-18511
44. Olson M.W., Toth M., Gervasi D.C., Sado Y., Ninomiya Y., and Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J. Biol. Chem. 273 (1998) 10672-10681
45. Caterina N.C., Windsor L.J., Bodden M.K., Yermovsky A.E., Taylor K.B., Birkedal-Hansen H., et al. Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1). Biochim. Biophys. Acta 1388 (1998) 21-34
46. Goldberg G.I., Strongin A., Collier I.E., Genrich L.T., and Marmer B.L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267 (1992) 4583-4591
47. Han Y.P., Nien Y.D., and Garner W.L. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J. Biol. Chem. 277 (2002) 27319-27327
48. Kim Y.S., Hwang S.Y., Kang H.Y., Sohn H., Oh S., Kim J.Y., et al. Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase. Mol. Cell. Proteomics 7 (2008) 1-14
49. Butler G.S., Apte S.S., Willenbrock F., and Murphy G. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J. Biol. Chem. 274 (1999) 10846-10851
50. Hayakawa T., Yamashita K., Ohuchi E., and Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell. Sci. 107 (1994) 2373-2379
51. Kolkenbrock H., Orgel D., Hecker-Kia A., Noack W., and Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198 (1991) 775-781